Tuesday, March 04, 2025 | 08:09 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Laurus Labs surges 6% to hit over 4-month high

Analysts remain optimistic on the company's outlook for FY23 & FY24 with new capacity addition for commercial usage for FDF and API segments, ARV business and robust growth expected in CS business.

Labs, Science, Laurus
Premium

Labs, Science, Laurus

SI Reporter Mumbai
Shares of Laurus Labs hit an over four-month high of Rs 587.65, surging 6 per cent on the BSE in Friday’s intra-day trade on heavy volumes. The stock of the pharmaceutical company was trading at the highest level since October 21, 2021. It had hit a record high of Rs 724 on August 12, 2021.

At 12:02 pm; Laurus Labs was up 4 per cent at Rs 577, as compared to a 0.20 per cent rise in the S&P BSE Sensex. The trading volumes on the counter jumped 1.3 times with a combined 2.9 million equity shares having changed

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in